The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global CD63 Antibody Market Research Report 2024

Global CD63 Antibody Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1742825

No of Pages : 117

Synopsis
CD63 antibody is a mouse, rabbit, pig and human antibody against CD63. CD63 was recognized in immunohistochemical staining and western blot.

Global CD63 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CD63 Antibody market research.

Growing patient base, launch of CD63 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD63 antibody market revenue.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global CD63 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Merck
  • Thermo Fisher Scientific
  • NSJ Bioreagents
  • LifeSpan BioSciences
  • Bioss
  • GeneTex
  • BioLegend
  • Leading Biology
  • RayBiotech
  • OriGene Technologies
  • Abnova Corporation
  • Abbexa
  • ProSci
  • Bio-Rad
  • EpiGentek
  • HUABIO
  • R and D Systems
  • BosterBio
  • Cell Signaling Technology
  • Novus Biologicals
  • Biobyt
  • Jingjie PTM BioLab

Segment by Type

  • Monoclonal
  • Polyclonal

Segment by Application

  • Immunochemistry (IHC)
  • Immunofluorescence (IF)
  • Immunoprecipitation (IP)
  • Western Blot (WB)
  • ELISA
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The CD63 Antibody report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

List of Tables
Table 1. Global CD63 Antibody Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global CD63 Antibody Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global CD63 Antibody Market Competitive Situation by Manufacturers in 2022
Table 4. Global CD63 Antibody Sales (L) of Key Manufacturers (2018-2023)
Table 5. Global CD63 Antibody Sales Market Share by Manufacturers (2018-2023)
Table 6. Global CD63 Antibody Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global CD63 Antibody Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market CD63 Antibody Average Price (US$/L) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of CD63 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of CD63 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD63 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of CD63 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD63 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD63 Antibody as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD63 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global CD63 Antibody Sales by Region (2018-2023) & (L)
Table 18. Global CD63 Antibody Sales Market Share by Region (2018-2023)
Table 19. Global CD63 Antibody Sales by Region (2024-2029) & (L)
Table 20. Global CD63 Antibody Sales Market Share by Region (2024-2029)
Table 21. Global CD63 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global CD63 Antibody Revenue Market Share by Region (2018-2023)
Table 23. Global CD63 Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global CD63 Antibody Revenue Market Share by Region (2024-2029)
Table 25. North America CD63 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America CD63 Antibody Sales by Country (2018-2023) & (L)
Table 27. North America CD63 Antibody Sales by Country (2024-2029) & (L)
Table 28. North America CD63 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America CD63 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe CD63 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe CD63 Antibody Sales by Country (2018-2023) & (L)
Table 32. Europe CD63 Antibody Sales by Country (2024-2029) & (L)
Table 33. Europe CD63 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe CD63 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific CD63 Antibody Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific CD63 Antibody Sales by Region (2018-2023) & (L)
Table 37. Asia Pacific CD63 Antibody Sales by Region (2024-2029) & (L)
Table 38. Asia Pacific CD63 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific CD63 Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America CD63 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America CD63 Antibody Sales by Country (2018-2023) & (L)
Table 42. Latin America CD63 Antibody Sales by Country (2024-2029) & (L)
Table 43. Latin America CD63 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America CD63 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa CD63 Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa CD63 Antibody Sales by Country (2018-2023) & (L)
Table 47. Middle East & Africa CD63 Antibody Sales by Country (2024-2029) & (L)
Table 48. Middle East & Africa CD63 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa CD63 Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global CD63 Antibody Sales (L) by Type (2018-2023)
Table 51. Global CD63 Antibody Sales (L) by Type (2024-2029)
Table 52. Global CD63 Antibody Sales Market Share by Type (2018-2023)
Table 53. Global CD63 Antibody Sales Market Share by Type (2024-2029)
Table 54. Global CD63 Antibody Revenue (US$ Million) by Type (2018-2023)
Table 55. Global CD63 Antibody Revenue (US$ Million) by Type (2024-2029)
Table 56. Global CD63 Antibody Revenue Market Share by Type (2018-2023)
Table 57. Global CD63 Antibody Revenue Market Share by Type (2024-2029)
Table 58. Global CD63 Antibody Price (US$/L) by Type (2018-2023)
Table 59. Global CD63 Antibody Price (US$/L) by Type (2024-2029)
Table 60. Global CD63 Antibody Sales (L) by Application (2018-2023)
Table 61. Global CD63 Antibody Sales (L) by Application (2024-2029)
Table 62. Global CD63 Antibody Sales Market Share by Application (2018-2023)
Table 63. Global CD63 Antibody Sales Market Share by Application (2024-2029)
Table 64. Global CD63 Antibody Revenue (US$ Million) by Application (2018-2023)
Table 65. Global CD63 Antibody Revenue (US$ Million) by Application (2024-2029)
Table 66. Global CD63 Antibody Revenue Market Share by Application (2018-2023)
Table 67. Global CD63 Antibody Revenue Market Share by Application (2024-2029)
Table 68. Global CD63 Antibody Price (US$/L) by Application (2018-2023)
Table 69. Global CD63 Antibody Price (US$/L) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 73. Merck CD63 Antibody Product
Table 74. Merck Recent Developments/Updates
Table 75. Thermo Fisher Scientific Corporation Information
Table 76. Thermo Fisher Scientific Description and Business Overview
Table 77. Thermo Fisher Scientific CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 78. Thermo Fisher Scientific CD63 Antibody Product
Table 79. Thermo Fisher Scientific Recent Developments/Updates
Table 80. NSJ Bioreagents Corporation Information
Table 81. NSJ Bioreagents Description and Business Overview
Table 82. NSJ Bioreagents CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 83. NSJ Bioreagents CD63 Antibody Product
Table 84. NSJ Bioreagents Recent Developments/Updates
Table 85. LifeSpan BioSciences Corporation Information
Table 86. LifeSpan BioSciences Description and Business Overview
Table 87. LifeSpan BioSciences CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 88. LifeSpan BioSciences CD63 Antibody Product
Table 89. LifeSpan BioSciences Recent Developments/Updates
Table 90. Bioss Corporation Information
Table 91. Bioss Description and Business Overview
Table 92. Bioss CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 93. Bioss CD63 Antibody Product
Table 94. Bioss Recent Developments/Updates
Table 95. GeneTex Corporation Information
Table 96. GeneTex Description and Business Overview
Table 97. GeneTex CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 98. GeneTex CD63 Antibody Product
Table 99. GeneTex Recent Developments/Updates
Table 100. BioLegend Corporation Information
Table 101. BioLegend Description and Business Overview
Table 102. BioLegend CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 103. BioLegend CD63 Antibody Product
Table 104. BioLegend Recent Developments/Updates
Table 105. Leading Biology Corporation Information
Table 106. Leading Biology Description and Business Overview
Table 107. Leading Biology CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 108. Leading Biology CD63 Antibody Product
Table 109. Leading Biology Recent Developments/Updates
Table 110. RayBiotech Corporation Information
Table 111. RayBiotech Description and Business Overview
Table 112. RayBiotech CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 113. RayBiotech CD63 Antibody Product
Table 114. RayBiotech Recent Developments/Updates
Table 115. OriGene Technologies Corporation Information
Table 116. OriGene Technologies Description and Business Overview
Table 117. OriGene Technologies CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 118. OriGene Technologies CD63 Antibody Product
Table 119. OriGene Technologies Recent Developments/Updates
Table 120. Abnova Corporation Corporation Information
Table 121. Abnova Corporation Description and Business Overview
Table 122. Abnova Corporation CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 123. Abnova Corporation CD63 Antibody Product
Table 124. Abnova Corporation Recent Developments/Updates
Table 125. Abbexa Corporation Information
Table 126. Abbexa Description and Business Overview
Table 127. Abbexa CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 128. Abbexa CD63 Antibody Product
Table 129. Abbexa Recent Developments/Updates
Table 130. ProSci Corporation Information
Table 131. ProSci Description and Business Overview
Table 132. ProSci CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 133. ProSci CD63 Antibody Product
Table 134. ProSci Recent Developments/Updates
Table 135. Bio-Rad Corporation Information
Table 136. Bio-Rad Description and Business Overview
Table 137. Bio-Rad CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 138. Bio-Rad CD63 Antibody Product
Table 139. Bio-Rad Recent Developments/Updates
Table 140. EpiGentek Corporation Information
Table 141. EpiGentek Description and Business Overview
Table 142. EpiGentek CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 143. EpiGentek CD63 Antibody Product
Table 144. EpiGentek Recent Developments/Updates
Table 145. HUABIO Corporation Information
Table 146. HUABIO Description and Business Overview
Table 147. HUABIO CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 148. HUABIO CD63 Antibody Product
Table 149. HUABIO Recent Developments/Updates
Table 150. R and D Systems Corporation Information
Table 151. R and D Systems Description and Business Overview
Table 152. R and D Systems CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 153. R and D Systems CD63 Antibody Product
Table 154. R and D Systems Recent Developments/Updates
Table 155. BosterBio Corporation Information
Table 156. BosterBio Description and Business Overview
Table 157. BosterBio CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 158. BosterBio CD63 Antibody Product
Table 159. BosterBio Recent Developments/Updates
Table 160. Cell Signaling Technology Corporation Information
Table 161. Cell Signaling Technology Description and Business Overview
Table 162. Cell Signaling Technology CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 163. Cell Signaling Technology CD63 Antibody Product
Table 164. Cell Signaling Technology Recent Developments/Updates
Table 165. Novus Biologicals Corporation Information
Table 166. Novus Biologicals Description and Business Overview
Table 167. Novus Biologicals CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 168. Novus Biologicals CD63 Antibody Product
Table 169. Novus Biologicals Recent Developments/Updates
Table 170. Biobyt Corporation Information
Table 171. Biobyt Description and Business Overview
Table 172. Biobyt CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 173. Biobyt CD63 Antibody Product
Table 174. Biobyt Recent Developments/Updates
Table 175. Jingjie PTM BioLab Corporation Information
Table 176. Jingjie PTM BioLab Description and Business Overview
Table 177. Jingjie PTM BioLab CD63 Antibody Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 178. Jingjie PTM BioLab CD63 Antibody Product
Table 179. Jingjie PTM BioLab Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. CD63 Antibody Distributors List
Table 183. CD63 Antibody Customers List
Table 184. CD63 Antibody Market Trends
Table 185. CD63 Antibody Market Drivers
Table 186. CD63 Antibody Market Challenges
Table 187. CD63 Antibody Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of CD63 Antibody
Figure 2. Global CD63 Antibody Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global CD63 Antibody Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global CD63 Antibody Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global CD63 Antibody Market Share by Application in 2022 & 2029
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Immunoprecipitation (IP)
Figure 11. Western Blot (WB)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global CD63 Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global CD63 Antibody Market Size (2018-2029) & (US$ Million)
Figure 16. Global CD63 Antibody Sales (2018-2029) & (L)
Figure 17. Global CD63 Antibody Average Price (US$/L) & (2018-2029)
Figure 18. CD63 Antibody Report Years Considered
Figure 19. CD63 Antibody Sales Share by Manufacturers in 2022
Figure 20. Global CD63 Antibody Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest CD63 Antibody Players: Market Share by Revenue in 2022
Figure 22. CD63 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global CD63 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America CD63 Antibody Sales Market Share by Country (2018-2029)
Figure 25. North America CD63 Antibody Revenue Market Share by Country (2018-2029)
Figure 26. United States CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe CD63 Antibody Sales Market Share by Country (2018-2029)
Figure 29. Europe CD63 Antibody Revenue Market Share by Country (2018-2029)
Figure 30. Germany CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific CD63 Antibody Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific CD63 Antibody Revenue Market Share by Region (2018-2029)
Figure 37. China CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Southeast Asia CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America CD63 Antibody Sales Market Share by Country (2018-2029)
Figure 45. Latin America CD63 Antibody Revenue Market Share by Country (2018-2029)
Figure 46. Mexico CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa CD63 Antibody Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa CD63 Antibody Revenue Market Share by Country (2018-2029)
Figure 52. Turkey CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE CD63 Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of CD63 Antibody by Type (2018-2029)
Figure 56. Global Revenue Market Share of CD63 Antibody by Type (2018-2029)
Figure 57. Global CD63 Antibody Price (US$/L) by Type (2018-2029)
Figure 58. Global Sales Market Share of CD63 Antibody by Application (2018-2029)
Figure 59. Global Revenue Market Share of CD63 Antibody by Application (2018-2029)
Figure 60. Global CD63 Antibody Price (US$/L) by Application (2018-2029)
Figure 61. CD63 Antibody Value Chain
Figure 62. CD63 Antibody Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’